Centiva Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,108
| Closed | -$331K | – | 1675 |
|
|
2025
Q1 | $331K | Buy |
10,108
+957
| +10% | +$31.3K | 0.01% | 860 |
|
|
2024
Q4 | $331K | Buy |
+9,151
| New | +$331K | 0.01% | 790 |
|
|
2024
Q3 | – | Sell |
-11,719
| Closed | -$313K | – | 1974 |
|
|
2024
Q2 | $313K | Buy |
+11,719
| New | +$313K | 0.01% | 1008 |
|
|
2024
Q1 | – | Sell |
-8,538
| Closed | -$247K | – | 1722 |
|
|
2023
Q4 | $247K | Buy |
+8,538
| New | +$247K | 0.01% | 870 |
|
|
2023
Q2 | – | Sell |
-6,977
| Closed | -$253K | – | 1513 |
|
|
2023
Q1 | $253K | Buy |
+6,977
| New | +$253K | 0.01% | 760 |
|
|
2020
Q2 | – | Sell |
-11,485
| Closed | -$207K | – | 572 |
|
|
2020
Q1 | $207K | Buy |
+11,485
| New | +$207K | 0.01% | 258 |
|